Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Neuropharmacology. 2018 Mar 1;142:240–250. doi: 10.1016/j.neuropharm.2018.02.033

Figure 2.

Figure 2

Dose-response effects of NBOMe compounds and their 2C analogs to inhibit binding of [3H]M100907 at 5-HT2A receptors in rat brain tissue. Various concentrations of test compounds were incubated with 1 nM [3H]M100907, and assays were terminated using rapid filtration. Non-specific binding was determined in the presence of 10 µM ketanserin. Data are % inhibition of specific binding in the absence of added drug and are expressed as mean ± SEM for N=3 experiments performed in triplicate.